UK Fails to Account for Hundreds of Synthetic Opioid-Related Deaths Due to Underreporting, Researchers Warn
A recent study published by researchers at King's College London has revealed that the UK may have underreported synthetic opioid-related deaths by up to 33%. The study found that toxicologists often struggle to detect nitazenes, a class of synthetic opioids that are hundreds of times stronger than heroin, in postmortem blood samples.
According to experts, the true number of deaths caused by these potent substances could be significantly higher due to concerns over underreporting. Nitazenes were originally developed as painkillers in the 1950s but their extreme potency led to a halt in their development due to addiction risks.
The National Crime Agency (NCA) previously reported that 333 fatalities in the UK were linked to nitazenes, but researchers believe this number may be an underestimate. By analyzing data from the UK National Programme on Substance Use Mortality and applying modelling techniques, the study found that an excess of drug deaths occurred in Birmingham in 2023, with a third more cases than reported.
The study's lead author, Dr Caroline Copeland, warned that if nitazenes are degrading in postmortem blood samples, it means that nearly all the true number of deaths are being missed. This leads to inaccurate data used to inform harm reduction strategies, ultimately resulting in preventable deaths.
As synthetic opioids continue to pose a growing public health concern, experts like Mike Trace, chief executive of the Forward Trust, have called for increased action from governments to tackle these deadly substances. With over 17,000 annual deaths related to drugs and alcohol, the call for comprehensive measures remains pressing.
Border Force has taken steps to combat this issue by training dogs to detect fentanyl and nitazenes, but more needs to be done to accurately measure the true scope of synthetic opioid-related deaths in the UK.
A recent study published by researchers at King's College London has revealed that the UK may have underreported synthetic opioid-related deaths by up to 33%. The study found that toxicologists often struggle to detect nitazenes, a class of synthetic opioids that are hundreds of times stronger than heroin, in postmortem blood samples.
According to experts, the true number of deaths caused by these potent substances could be significantly higher due to concerns over underreporting. Nitazenes were originally developed as painkillers in the 1950s but their extreme potency led to a halt in their development due to addiction risks.
The National Crime Agency (NCA) previously reported that 333 fatalities in the UK were linked to nitazenes, but researchers believe this number may be an underestimate. By analyzing data from the UK National Programme on Substance Use Mortality and applying modelling techniques, the study found that an excess of drug deaths occurred in Birmingham in 2023, with a third more cases than reported.
The study's lead author, Dr Caroline Copeland, warned that if nitazenes are degrading in postmortem blood samples, it means that nearly all the true number of deaths are being missed. This leads to inaccurate data used to inform harm reduction strategies, ultimately resulting in preventable deaths.
As synthetic opioids continue to pose a growing public health concern, experts like Mike Trace, chief executive of the Forward Trust, have called for increased action from governments to tackle these deadly substances. With over 17,000 annual deaths related to drugs and alcohol, the call for comprehensive measures remains pressing.
Border Force has taken steps to combat this issue by training dogs to detect fentanyl and nitazenes, but more needs to be done to accurately measure the true scope of synthetic opioid-related deaths in the UK.